CN1186318C - 新的苯磺胺化合物、其制备方法以及含有它们的药物组合物 - Google Patents

新的苯磺胺化合物、其制备方法以及含有它们的药物组合物 Download PDF

Info

Publication number
CN1186318C
CN1186318C CNB021241627A CN02124162A CN1186318C CN 1186318 C CN1186318 C CN 1186318C CN B021241627 A CNB021241627 A CN B021241627A CN 02124162 A CN02124162 A CN 02124162A CN 1186318 C CN1186318 C CN 1186318C
Authority
CN
China
Prior art keywords
formula
compound
phenyl
ethyl
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB021241627A
Other languages
English (en)
Chinese (zh)
Other versions
CN1397547A (zh
Inventor
G·拉维勒
T·迪比费
B·西默蒂埃
T·韦伯朗
S·西莫内
C·韦塞特－库尔蔡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Publication of CN1397547A publication Critical patent/CN1397547A/zh
Application granted granted Critical
Publication of CN1186318C publication Critical patent/CN1186318C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
CNB021241627A 2001-07-13 2002-07-15 新的苯磺胺化合物、其制备方法以及含有它们的药物组合物 Expired - Fee Related CN1186318C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0109339A FR2827280B1 (fr) 2001-07-13 2001-07-13 Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR0109339 2001-07-13

Publications (2)

Publication Number Publication Date
CN1397547A CN1397547A (zh) 2003-02-19
CN1186318C true CN1186318C (zh) 2005-01-26

Family

ID=8865462

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021241627A Expired - Fee Related CN1186318C (zh) 2001-07-13 2002-07-15 新的苯磺胺化合物、其制备方法以及含有它们的药物组合物

Country Status (23)

Country Link
US (1) US6541471B1 (https=)
EP (1) EP1275641B1 (https=)
JP (1) JP3770858B2 (https=)
KR (1) KR100503157B1 (https=)
CN (1) CN1186318C (https=)
AR (1) AR035257A1 (https=)
AT (1) ATE286877T1 (https=)
AU (1) AU2002300092B2 (https=)
BR (1) BR0202685A (https=)
CA (1) CA2393995C (https=)
DE (1) DE60202554T2 (https=)
DK (1) DK1275641T3 (https=)
EA (1) EA005376B1 (https=)
ES (1) ES2234994T3 (https=)
FR (1) FR2827280B1 (https=)
HU (1) HUP0202284A3 (https=)
MX (1) MXPA02006853A (https=)
NO (1) NO20023390L (https=)
NZ (1) NZ520141A (https=)
PL (1) PL355009A1 (https=)
PT (1) PT1275641E (https=)
SI (1) SI1275641T1 (https=)
ZA (1) ZA200205597B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106083546A (zh) * 2016-06-20 2016-11-09 上海引盛生物科技有限公司 一种3,5‑二溴苯甲醛的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02304022A (ja) * 1989-05-18 1990-12-17 Mitsubishi Kasei Corp セロトニン拮抗剤
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
EP0472053B1 (en) * 1990-08-20 1998-06-17 Eisai Co., Ltd. Sulfonamide derivatives
TW219358B (https=) * 1991-12-20 1994-01-21 Hokuriku Pharmaceutical
GB9220137D0 (en) * 1992-09-23 1992-11-04 Pfizer Ltd Therapeutic agents
JPH0753505A (ja) * 1992-10-01 1995-02-28 Hokuriku Seiyaku Co Ltd ベンゼンスルホンアミド誘導体及びその用途
FR2760235B1 (fr) * 1997-02-28 1999-04-09 Adir Nouveaux derives de benzenesulfonylamine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
EP1275641A3 (fr) 2003-05-14
MXPA02006853A (es) 2005-07-25
DK1275641T3 (da) 2005-04-25
CA2393995A1 (fr) 2003-01-13
AU2002300092B2 (en) 2007-07-12
NO20023390L (no) 2003-01-14
HU0202284D0 (https=) 2002-09-28
PL355009A1 (en) 2003-01-27
EA200200666A1 (ru) 2003-02-27
DE60202554D1 (de) 2005-02-17
ATE286877T1 (de) 2005-01-15
BR0202685A (pt) 2003-05-06
FR2827280A1 (fr) 2003-01-17
PT1275641E (pt) 2005-05-31
NO20023390D0 (no) 2002-07-12
EA005376B1 (ru) 2005-02-24
KR100503157B1 (ko) 2005-07-25
FR2827280B1 (fr) 2003-10-31
ES2234994T3 (es) 2005-07-01
EP1275641B1 (fr) 2005-01-12
DE60202554T2 (de) 2005-12-29
SI1275641T1 (en) 2005-04-30
CN1397547A (zh) 2003-02-19
HK1050675A1 (en) 2003-07-04
ZA200205597B (en) 2003-03-27
JP2003113156A (ja) 2003-04-18
EP1275641A2 (fr) 2003-01-15
AR035257A1 (es) 2004-05-05
KR20030007174A (ko) 2003-01-23
US6541471B1 (en) 2003-04-01
HUP0202284A2 (hu) 2003-02-28
CA2393995C (fr) 2008-06-10
HUP0202284A3 (en) 2005-02-28
NZ520141A (en) 2003-11-28
JP3770858B2 (ja) 2006-04-26

Similar Documents

Publication Publication Date Title
CN1229351C (zh) 杂环化合物和治疗心力衰竭及其它疾病的方法
CN1193025C (zh) 新的1,3－二氢－2h－吲哚－2－酮衍生物,它们的制备方法以及含有它们的药物组合物
CN1072220C (zh) 作为神经激肽受体拮抗剂的1－苯甲酰基－2－(吲哚基－3－烷基)－哌嗪衍生物
CN1198613C (zh) 氨基苯氧基乙酸衍生物和含有它们的药用组合物
CN1304382C (zh) 用于治疗炎性、免疫或心血管疾病的新的p2x7受体拮抗剂
CN1030251C (zh) 取代的4-(喹啉-2-基-甲氧基)苯乙酸衍生物的制备方法
CN1136213C (zh) 新的苯并噻吩、苯并呋喃和吲哚化合物、其制备方法和含有它们的药物组合物
CN1153765C (zh) 具有神经营养和保护活性的4-芳基-1-苯基烷基-1,2,3,6-四氢吡啶
CN1178911C (zh) 吡咯烷与哌啶衍生物和它们用于治疗神经变性疾病的用途
CN1035178C (zh) 芳酰胺衍生物
CN1134423C (zh) 粘连受体拮抗剂
HK1050357A1 (en) New -amino acid sulphonyl compounds, a process for their preparation and pharmaceutical compositions containing them
CN1758909A (zh) 作为新MDM2－p53抑制剂的取代的哌啶类
CN1246110A (zh) 芳基哌啶子基丙醇和芳基哌嗪子基丙醇衍生物和含有它们的药物
CN1510034A (zh) 新型吲唑化合物,其制备方法及含有它们的药物组合物
CN1049662A (zh) 香豆素衍生物及其制备和在治疗脑血管失调中的应用
CN1124026A (zh) 新型哌啶基硫代吲哚衍生物，它们的制备方法，和含有它们的药物组合物，作为止痛药的用途
CN1160332C (zh) 用于治疗抑郁症的n-芳氧基乙基胺衍生物
CN1099752A (zh) 新型酰氨烷基-和亚氨烷基-哌嗪
CN1186318C (zh) 新的苯磺胺化合物、其制备方法以及含有它们的药物组合物
CN1189466C (zh) 新的直链或环状脲、其制备方法和含有它们的药物组合物
CN1129599C (zh) 取代的苯并噻嗪/噁嗪－2－胺衍生物、共制备方法及其应用
CN1170537C (zh) 取代的1-(哌啶-4-基)-3-芳基异硫脲、其制备方法及其在制备药物中的应用
CN1231466C (zh) 新型哌啶衍生物
CN1628099A (zh) 水溶性苯基甘氨酸衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050126